Nadim Ahmed - Mar 5, 2022 Form 4 Insider Report for Cullinan Oncology, Inc. (CGEM)

Role
President and CEO, Director
Signature
/s/ Jeffrey Trigilio, Attorney-in-Fact
Stock symbol
CGEM
Transactions as of
Mar 5, 2022
Transactions value $
$0
Form type
4
Date filed
3/7/2022, 08:50 PM
Previous filing
Oct 20, 2021
Next filing
Jun 7, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CGEM Performance Stock Unit Award $0 +215K $0.00 215K Mar 5, 2022 Common Stock 215K Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each performance stock unit represents a contingent right to receive one share of common stock of the Issuer. The performance stock units vest upon the Issuer's common stock achieving a specified price per share.